EcoDrugPlus

Kinesin Family Member 11

Ensembl ID : ENSPLAG00000001549
Gene Symbol: KIF11
3 Cross references
201 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSPLAG00000011270
Gene Symbol: KIF5B
4 Cross references
236 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSPLAG00000007324
Gene Symbol: KIF5B
4 Cross references
234 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSPLAG00000017604
Gene Symbol: LTA4H
3 Cross references
203 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSPLAG00000023425
Gene Symbol: LOC106962732
3 Cross references
142 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSPLAG00000023415
Gene Symbol: LOC106962733
3 Cross references
157 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSPLAG00000006905
Gene Symbol: LTB4R2B
1 Cross references
167 Possible Orthologues:

Lutropin-Choriogonadotropic Hormone Receptor-Like

Ensembl ID : ENSPLAG00000001557
Gene Symbol: LOC106948651
4 Cross references
200 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSPLAG00000021417
Gene Symbol: KDM1A
3 Cross references
212 Possible Orthologues:

Lysyl Oxidase Homolog 2a-Like

Ensembl ID : ENSPLAG00000010841
Gene Symbol: LOC106956981
3 Cross references
209 Possible Orthologues:

Lysyl Oxidase Homolog 2b-Like

Ensembl ID : ENSPLAG00000019197
Gene Symbol: LOC106955432
3 Cross references
211 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor 1-Like

Ensembl ID : ENSPLAG00000018549
Gene Symbol: LOC106939822
3 Cross references
63 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).